Vancouver General Hospital is a medical facility located in Vancouver, British Columbia. It is the largest facility in the Vancouver Hospital and Health Sciences Centre group of medical facilities. VGH is Canada's third largest hospital by bed count, after Hamilton General Hospital, and Foothills Medical Centre.

During the past decade, Vancouver Coastal Health conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 11 clinical trials were completed, i.e. on average, 78.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vancouver Coastal Health" #1 sponsor was "University of British Columbia" with 9 trials, followed by "Idorsia Pharmaceuticals Ltd." with 3 trials sponsored, "Daren K. Heyland" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "United Therapeutics" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vancouver Coastal Health" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 4 trials as a collaborator, "Brain Canada" with 2 trials as a collaborator, "Heart and Stroke Foundation of Canada" with 2 trials as a collaborator, "Vancouver Coastal Health" with 2 trials as a collaborator and "Vancouver Coastal Health Research Institute" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Vancouver Coastal Health" are "Critical Illness" (3 trials), "Fabry Disease" (2 trials), "Myocardial Infarction" (2 trials), "Pulmonary Arterial Hypertension" (2 trials) and "Acute Cerebral Ischemia" (1 trials). Many other conditions were trialed in "Vancouver Coastal Health" in a lesser frequency.

Most popular intervention types in "Vancouver Coastal Health" are "Drug" (18 trials), "Behavioral" (5 trials), "Device" (5 trials), "Other" (5 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Lucerastat" (2 trials), "123I-meta-iodobenzylguanidine" (1 trials), "Acetaminophen" (1 trials) and "Alefacept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vancouver Coastal Health" are 35 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are 8 active trials in "Vancouver Coastal Health". 1 are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 19 completed trials in Vancouver Coastal Health, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Vancouver Coastal Health, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 11 trials that are defined as “Not Applicable".

Vancouver Coastal Health has several departments that took part in Clinical trials: "GF Strong Rehabilitation Centre" - 33 trials, "Vancouver General Hospital Intensive Care Unit" - 2 trials